HTS01037 is primarily utilized in research and development within the pharmaceutical industry. It is often explored for its potential therapeutic properties, particularly in targeting specific biological pathways or enzymes involved in disease mechanisms. Researchers investigate its efficacy in preclinical studies, focusing on its ability to modulate cellular processes or inhibit protein interactions that contribute to conditions such as cancer, inflammation, or metabolic disorders. Additionally, HTS01037 may serve as a lead compound in drug discovery, guiding the synthesis of derivatives with improved potency, selectivity, and safety profiles. Its application extends to high-throughput screening assays, where it helps identify novel drug candidates or validate biological targets for further investigation.